---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-002939"
form_type: "8-K"
ticker: "CGTX"
cik: "0001455365"
company_name: "COGNITION THERAPEUTICS INC"
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:07:07.550423+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Cognition Therapeutics files investor presentation with no material updates disclosed

## Summary
- Filed an investor presentation under Item 7.01 for Regulation FD purposes.
- Presentation slide titled 'Targeting Pathogenic Oligomers: A Disruptive Approach to Neurodegenerative Diseases'.
- No financial results, pipeline milestones, or guidance changes are included in the filing.
- Filing is a routine disclosure; no new material events reported.

## SEC filing metadata
- accession: 0001104659-25-002939
- form_type: 8-K
- ticker: CGTX
- cik: 0001455365
- company_name: COGNITION THERAPEUTICS INC
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1455365/000110465925002939/0001104659-25-002939-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1455365/000110465925002939/tm253137d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-002939
- JSON: https://secwatch.observer/filing/0001104659-25-002939.json
- Plain text: https://secwatch.observer/filing/0001104659-25-002939.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.